Michael Schwarzl
Overview
Explore the profile of Michael Schwarzl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ludwig S, Strotmann L, Schrage B, Koell B, Coisne A, Scotti A, et al.
Struct Heart
. 2024 Aug;
8(4):100322.
PMID: 39100583
Background: Transcatheter mitral valve replacement (TMVR) represents a novel treatment option for patients with mitral regurgitation (MR), but little is known about the hemodynamic impact of MR elimination following TMVR....
2.
Kahle A, Gude R, Schwarzl J, Munkler P, Akbulak R, Jahnke C, et al.
J Cardiovasc Dev Dis
. 2022 Aug;
9(8).
PMID: 36005407
Myocarditis is characterized by various clinical manifestations, with ventricular arrhythmia (VA) as a frequent symptom at initial presentation. Here, we investigated characteristics and prognostic relevance of VA in patients with...
3.
Schwarzl J, Schleberger R, Kahle A, Holler A, Schwarzl M, Schaeffer B, et al.
J Cardiovasc Electrophysiol
. 2020 Dec;
32(2):376-388.
PMID: 33368769
Introduction: Substrate-based catheter ablation approaches to ventricular tachycardia (VT) focus on low-voltage areas and abnormal electrograms. However, specific electrogram characteristics in sinus rhythm are not clearly defined and can be...
4.
Jin G, Manninger M, Adelsmayr G, Schwarzl M, Alogna A, Schonleitner P, et al.
ESC Heart Fail
. 2020 Nov;
8(1):151-161.
PMID: 33251761
Aims: Atrial contractile dysfunction contributes to worse prognosis in hypertensive heart disease (HHD), but the role of cardiomyocyte dysfunction in atrial remodelling in HHD is not well understood. We investigated...
5.
Becher P, Twerenbold R, Schrage B, Schmack B, Sinning C, Fluschnik N, et al.
J Crit Care
. 2020 Jan;
56:100-105.
PMID: 31896442
Purpose: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is an increasingly used treatment option for patients in need of mechanical cardiopulmonary support, while available outcome data is limited. The aim of this...
6.
Abawi D, Faragli A, Schwarzl M, Manninger M, Zweiker D, Kresoja K, et al.
BMC Cardiovasc Disord
. 2019 Oct;
19(1):217.
PMID: 31615415
Background: Cardiac power output (CPO), derived from the product of cardiac output and mean aortic pressure, is an important yet underexploited parameter for hemodynamic monitoring of critically ill patients in...
7.
Strangl F, Schwarzl M, Schrage B, Soffker G
Eur Heart J Case Rep
. 2019 Apr;
2(3):yty088.
PMID: 31020165
Background: Extracorporeal life support (ECLS) by veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a valuable treatment option during severe cardiogenic shock and during cardiac arrest unresponsive to conventional management. It is...
8.
Bode D, Lindner D, Schwarzl M, Westermann D, Deissler P, Primessnig U, et al.
J Mol Cell Cardiol
. 2019 Apr;
131:53-65.
PMID: 31005484
Aims: Atrial contractile dysfunction is associated with increased mortality in heart failure (HF). We have shown previously that a metabolic syndrome-based model of HFpEF and a model of hypertensive heart...
9.
Bacmeister L, Schwarzl M, Warnke S, Stoffers B, Blankenberg S, Westermann D, et al.
Basic Res Cardiol
. 2019 Mar;
114(3):19.
PMID: 30887214
Heart failure is a consequence of various cardiovascular diseases and associated with poor prognosis. Despite progress in the treatment of heart failure in the past decades, prevalence and hospitalisation rates...
10.
Voss S, Kruger S, Scherschel K, Warnke S, Schwarzl M, Schrage B, et al.
Biomolecules
. 2019 Jan;
9(2).
PMID: 30678084
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine known to play a major role in inflammatory diseases such as myocardial infarction (MI), where its expression increases. Cardio protective functions...